BioCardia Files 8-K: Regulation FD & Exhibits
Ticker: BCDA · Form: 8-K · Filed: Apr 15, 2025 · CIK: 925741
| Field | Detail |
|---|---|
| Company | Biocardia, Inc. (BCDA) |
| Form Type | 8-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, exhibits, sec-filing
Related Tickers: BCDA
TL;DR
BioCardia filed an 8-K for Reg FD and exhibits. Nothing major disclosed yet.
AI Summary
On April 15, 2025, BioCardia, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This filing indicates BioCardia, Inc. is providing required disclosures and financial information to the SEC, which is standard for public companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, not indicating any immediate material changes or risks.
Key Players & Entities
- BioCardia, Inc. (company) — Registrant
- April 15, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 320 Soquel Way Sunnyvale, California 94085 (address) — Principal executive offices
FAQ
What specific information is being disclosed under Regulation FD?
The provided excerpt does not detail the specific information disclosed under Regulation FD, only that it is an item of the filing.
What financial statements are included in this filing?
The excerpt indicates that 'Financial Statements and Exhibits' are part of the filing, but does not list the specific statements.
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to present Financial Statements and Exhibits.
When was BioCardia, Inc. incorporated?
BioCardia, Inc. was incorporated in Delaware, as stated in the filing.
What is BioCardia, Inc.'s principal executive office address?
BioCardia, Inc.'s principal executive office is located at 320 Soquel Way, Sunnyvale, California 94085.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 15, 2025 regarding BioCardia, Inc. (BCDA).